Market Access
Solution Spotlight: Acumetis Model Builder
Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Articles
AstraZeneca’s first direct-to-patient program – one year on

AstraZeneca’s first direct-to-patient program – one year on

Steven Davis, Executive Director, Foundation Brands, AstraZeneca shares his views on ARIMIDEX Direct – AstraZeneca’s first direct-to-patient program, and how successful its first year has been. A year ago, AstraZeneca announced its first direct-to-patient program in the US, whereby patients with a valid prescription could...

Articles
How much is that cure in the window? Pharma testing the waters of the cure

How much is that cure in the window? Pharma testing the wate...

Melissa Hogan, mother of a patient with a rare disease, explores the possibility of pharma developing cures for rare diseases. No one's ever asked me to run in a "Race for the Treatment." It certainly doesn't sound as motivating as a Race for the Cure…

Articles
Being diagnosed with cryoglobulinemia

Being diagnosed with cryoglobulinemia

Diane Dike, Ph.D. shares her experience in being diagnosed with a rare disease and discusses the importance of online patient communities when it comes to dealing with a diagnosis. It can be lonely, scared and confusing being a patient diagnosed with a rare disease. In Europe, a disease is considered rare when...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Market Access
Solution Spotlight: Acumetis Model Builder
Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D